Neil Kramer, MD, is a rheumatologist at Atlantic Health Overlook Medical Center, Physician Researcher, Atlantic Health ...
CAR-T therapy, which transformed the treatment of B-cell blood cancers, is now being tested as a way to reset the immune system in severe ...
Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthropy, data collection, molecular science, and increasingly sophisticated ...
A Bullish Biotech Funding Market and a Higher Bar for Companies Seeking Capital - Importance of milestone-based development ...
Calvin Chao, MD, MBA, Vice President of Medical Science at Artera, is a medical executive with expertise spanning oncology, ...
What 195 Clinical Trials Reveal About the State of Artificial Intelligence in Oncology and Hematology in 2026.
Artificial intelligence (AI) is increasingly used in oncology to support tasks such as clinical-trial matching, evidence ...
Daiichi Sankyo and Merck & Co/MSD have withdrawn their U.S. application seeking accelerated approval of ifinatamab deruxtecan ...
Rare cancers can expose a difficult gap between advances in precision oncology and the systems that determine access to ...
Biotech leadership cannot stay static as a company moves from the benchtop to the clinic, writes, CEO of CERo Therapeutics.
Breast cancer prevention remains an important opportunity to move care earlier in the disease continuum, particularly by ...
For patients with early-stage lung cancer who cannot undergo surgery, precision radiation therapy is the main curative-intent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results